The Efficacy of Velcade on Bone Tissue During Myelomatosis (Bone Marrow Cancer)

• Status: Completed
• Trial end date: 2009-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The primary objective of the the study is to investigate the changes in bone remodeling during Velcade treatment.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Vejle Hospital
• Collaborator: Odense University Hospital
• Treatments: Bortezomib

Criteria

Inclusion Criteria:

• Previously untreated multiple myeloma

Exclusion Criteria:

• Use of bisfosfonates